Naptumomab estafenatox

Tax included
Naptumomab estafenatox (ABR-217620) is a tumor targeting superantigen (TTS). Naptumomab estafenatox is a fusion protein containing an anti-5T4 antibody and a SEA/E-120 superantige. Naptumomab estafenatox can be used for the research of lung cancer.
MedChemExpress 
HY-P99749

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
Cancer-programmed cell death
CAS
676258-98-3